Morning Overview on MSN
A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older saw the biggest benefit
A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial Clinical trials frequently include ...
PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DEDThis FDA-aligned trial targets ...
MSN on MSNOpinion
Dogs vs statins: A randomized controlled trial
A thought experiment in prevention: What if dogs do more for cardiovascular health than statins? Let’s examine the data, ...
Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC) ...
Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued ...
MedPage Today on MSN
Late-Breaking Studies at EULAR Paint Rosy Picture of Rheumatology's Future
Psoriatic arthritis biologics square off, novel molecules and mechanisms, and old drugs ma ...
First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results